UNILATERAL TRANSIENT VISION LOSS FOLLOWING BILATERAL INTRAVITREAL OCRIPLASMIN – CASE REPORT WITH TWO YEARS FOLLOW UP

Abstract Background: Ocriplasmin is a serine protease approved for the treatment of symptomatic vitreomacular traction (VMT). Post-marketing experience has revealed safety concerns. Materials and Methods: Retrospective case report. Clinical and surgical data were analyzed.  Results: We report a case...

Full description

Bibliographic Details
Main Author: Proença, Helena (author)
Other Authors: Pinto, Filomena (author), Campos, Fátima (author), Vaz-Pereira, Sara (author)
Format: report
Language:eng
Published: 2020
Subjects:
Online Access:https://doi.org/10.48560/rspo.20166
Country:Portugal
Oai:oai:ojs.revistas.rcaap.pt:article/20166